HDA and its primary pharmaceutical distributor members — a critical link between nearly 1,500 manufacturers and more than 180,000 healthcare providers — are continuing to rise to the challenge of the COVID-19 pandemic.

With the federal government and healthcare supply chain engaged in one of the largest public immunization efforts in recent memory, HDA distributor members have worked tirelessly to navigate the demands of the nationwide vaccine rollout. Our members are working with the federal government and states to make sure vaccines get where they are needed, supporting our pharmacy and provider partners so they can put shots in arms, and amplifying efforts that address vaccine hesitancy and encourage immunizations. And through their logistics expertise, HDA members are finding the most efficient ways to reliably deliver novel COVID-19 therapeutics, antivirals and boosters, as directed by the federal government.

Named critical infrastructure by the federal government, distributors continue to adapt and adjust to the global pandemic, protecting the steady supply of critical, lifesaving medicines to hospitals, pharmacies, providers and patients, while maintaining business continuity plans to safeguard the health and safety of their dedicated frontline employees. By leveraging strong relationships at both ends of the supply chain, and working in concert with federal, state and local officials, distributors are meeting the daily healthcare needs of all Americans — from the biggest cities to the smallest towns.

HDA and our members will continue to coordinate closely with public- and private-sector stakeholders as the situation evolves; this page will be updated as additional information is made available. For additional stories on distributors' vital role in the COVID-19 response, visit www.HealthDelivered.org/COVID19.